ProKidney Corp
NASDAQ:PROK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
ProKidney Corp
NASDAQ:PROK
|
US |
|
Gentech Holdings Inc
OTC:GTEH
|
US |
|
C
|
CIE Automotive SA
MAD:CIE
|
ES |
|
U
|
Ultrapetrol (Bahamas) Ltd
OTC:ULTRF
|
BS |
|
Radico Khaitan Ltd
NSE:RADICO
|
IN |
|
CHC Healthcare Group
TWSE:4164
|
TW |
|
P
|
Playwith Inc
KOSDAQ:023770
|
KR |
|
Qingdao Haier Biomedical Co Ltd
SSE:688139
|
CN |
|
Universe Group PLC
LSE:UNG
|
UK |
|
Selva Gida Sanayi AS
IST:SELVA.E
|
TR |
|
A
|
Akanda Corp
NASDAQ:AKAN
|
UK |
|
Hyundai Doosan Infracore Co Ltd
KRX:042670
|
KR |
|
O
|
Outin Futures Co Ltd
KOSDAQ:227610
|
KR |
|
Concraft Holding Co Ltd
TWSE:4943
|
TW |
|
Swiss Water Decaffeinated Coffee Inc
TSX:SWP
|
CA |
|
D
|
Digital Media Solutions Inc
OTC:DMSL
|
US |
|
T
|
Tbo Tek Ltd
NSE:TBOTEK
|
IN |
|
Zheneng Jinjiang Environment Holding Co Ltd
SGX:BWM
|
CN |
|
Techtronic Industries Co Ltd
HKEX:669
|
HK |
|
N
|
Northern Textiles And Garments JSC
VN:TET
|
VN |
|
C
|
Cobalt Blue Holdings Ltd
OTC:CBBHF
|
AU |
|
Toho Gas Co Ltd
TSE:9533
|
JP |
|
O
|
Onoff AG
XETRA:2QU
|
DE |
|
Kovai Medical Center and Hospital Ltd
NSE:KOVAI
|
IN |
Multiples-Based Value
The Multiples-Based Value for ProKidney Corp (PROK) under the Base Case is hidden USD. Compared with the current market price of 2.01 USD, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PROK Competitors Multiples
ProKidney Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
P
|
ProKidney Corp
NASDAQ:PROK
|
605.2m USD | 677.7 | -8.8 | -2.1 | -2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.5B USD | 6 | 88 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.7B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD | 9.3 | 28.4 | 21.3 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD | 5.6 | 17.7 | 13.1 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 12.4 | 39.7 | 43.1 | 44 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 2.9 | 32.4 | 10.9 | 13.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |